Through our fellow Quotient Bioscience company GR Micro Ltd, HFL provides a comprehensive range of microbiology services to support the development of anti-microbial agents in both human and veterinary medicine.

GR Micro Ltd is well equipped to investigate the antimicrobial activity of novel compounds from early discovery through to phase IV surveillance clinical trials.

Services include:

• Anti-infective screening
• MIC and resistance evaluations
• Molecular bacteriology and virology
• Surveillance studies

Drawing upon an extensive current library collection of clinical isolates, the spectrum of activity of new anti-microbial agents against microbiologically and geographically diverse strains can be readily assessed.

If resistance is observed, G.R. Micro Ltd can identify the mechanisms responsible and epidemiological markers using molecular biology techniques.

This comprehensive investigative ability provides valuable data to enable clients to assess the commercial potential of developmental compounds for drug development and clinical trials.

 

Please click here to contact us using the contact form

 

or email info@grmicro.co.uk

 

or visit http://www.grmicro.co.uk